e-Ultimaster Left Main | Terumo Interventional Systems

Overview

・1,099 patients with Left main lesions treated with Ultimaster™ DES showed acceptable clinical outcomes.

Study Design

clinical_evidence_e_ultimaster_left_main_study_design

Primary Endpoint

Target lesion failure at 1 year

・Cardiac death, target vessel MI or clinically driven target lesion revascularization

Study Outline

Patient background

Patient characteristics	LM only n= 514	LM + MV n= 585	p-value
Mean age, year	69.2±11.0	68.9±10.9	P=0.65
BMI kg/m²	27.2±5.1	27.6±5.6	P=0.25
Hyperlipidaemia %	59.6	63.3	P=0.23
Diabetes, %	33.7	33.2	P=0.90
Hypertension, %	74.7	71.6	P=0.27
Previous PCI %	39.5	36.9	P=0.41
Previous CABG%	22	18	P=0.10

Patient characteristics	LM only n= 514	LM + MV n= 585	p-value
Lesion longer > 25 mm %	44.8	56.1	P<0.001
Calcified	32.2	32.56	P<0.001
Num of stents/pt, n	1.4± 0.7	2.2 ±1.2	P<0.0001
Total stent length/pt, mm	30.0± 20.3	48.9± 32.2	P<0.0001
Syntax < 22 %	68.8	42.4	P<0.0001
Syntax 23-32	21.9	40.1	P=0.001
Post dilatation %	69.7	74.9	P=0.06
Radial access %	68.5	68	P=0.90
OFDI + IVUS %	36.5	27.1	P<0.01
Direct stenting %	29.4	51.3	P<0.0001

Result

clinical_evidence_e_ultimaster_primary_endopoint_result

Reference